Introduction: In addition to the prevention of tobacco consumption, the establishment and assurance of high-quality treatment for harmful use and dependence on tobacco products remains an important health-related task in Germany. Regular updating of the Association of the Scientific Medical Societies (AWMF) S3 guideline “Smoking and Tobacco Dependence: Screening, Diagnosis, and Treatment” (Tobacco Guideline) offers a sustainable and reputable source of knowledge on smoking cessation. Methods: Under the auspices of the German Society for Psychiatry, Psychotherapy, Psychosomatics, and Neurology (DGPPN) and the German Society for Addiction Research and Addiction Therapy (DG-Sucht), the Tobacco Guideline was revised in 2019–2020 by 63 experts, who were involved in the development process of the text, in 11 working groups. Undue influence of conflicts of interest on the guideline could be minimized through careful conflict of interest management. Delegates from 50 professional societies discussed the 80 guideline recommendations and voted online. Results: In addition to recommendations for screening and diagnostics, the Tobacco Guideline takes a positive stance towards the use of low-threshold counseling and support services. If, due to the severity of the tobacco-related disorder, brief counseling, telephone counseling, or internet- or smartphone-based methods are not sufficiently effective, individual or group behavioral therapy, possibly in combination with medication, is indicated. If nicotine replacement therapy is not effective, varenicline or bupropion should be offered. Alternative strategies with a lower level of recommendation are hypnotherapy, mindfulness-based treatments, or medication with cytisine. In adolescents and pregnant women, the use of medication should be limited to well-specified exceptions and nicotine replacement. The mean agreement with the recommendations reached a value of 98%. A general overview of the treatment recommendations of the Tobacco Guideline is provided by three clinical algorithms.
Eur Addict Res

中文翻译：

---

S3 指南“吸烟和烟草依赖：筛查、诊断和治疗” – 简短版

简介：除了预防烟草消费外，建立和保证针对有害使用和烟草制品依赖的高质量治疗仍然是德国一项与健康相关的重要任务。科学医学会协会 (AWMF) S3 指南“吸烟和烟草依赖：筛查、诊断和治疗”（烟草指南）的定期更新提供了关于戒烟的可持续和有信誉的知识来源。方法：在德国精神病学、心理治疗、心身学和神经病学学会 (DGPPN) 和德国成瘾研究和成瘾治疗学会 (DG-Sucht) 的主持下，63 位专家在 2019-2020 年对烟草指南进行了修订，他们分别是参与文本的制定过程，在 11 个工作组中。通过谨慎的利益冲突管理，可以最大限度地减少利益冲突对指南的不当影响。来自 50 个专业协会的代表讨论了 80 条指南建议并在线投票。结果：除了对筛查和诊断的建议外，烟草指南还对使用低门槛咨询和支持服务持积极态度。如果由于烟草相关疾病的严重性，简短的咨询、电话咨询或基于互联网或智能手机的方法不够有效，则表明可能与药物相结合的个人或团体行为治疗。如果尼古丁替代疗法无效，应提供伐尼克兰或安非他酮。推荐级别较低的替代策略是催眠疗法、基于正念的治疗或金雀花碱药物治疗。在青少年和孕妇中，药物的使用应仅限于明确规定的例外情况和尼古丁替代品。与建议的平均一致性达到 98%。三种临床算法提供了烟草指南治疗建议的一般概述。
欧洲瘾君子水库